Skip to main content
DNA Labs India

PSEN2 Gene Alzheimer Disease Type 4 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

PSEN2 Gene Alzheimer Disease Type 4 NGS Genetic Test

Short Name: PSEN2 NGS Test

Also known as: PSEN2 Gene Mutation Analysis, Presenilin-2 Gene Sequencing, Alzheimer Disease Type 4 Genetic Test, PSEN2-Related Alzheimer Disease NGS Test

PSEN2 Gene Alzheimer Disease Type 4 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Results are usually available in 3 to 4 weeks. This duration includes DNA extraction, quality control, NGS sequencing, data analysis, variant interpretation, and report preparation.. Free home collection in 300+ cities across India.

NGS Genetic TestAdults (usually 18 years and older)🏠 Home Collection

🩺 Medically Reviewed By

Overview

The main purpose of this NGS genetic test is to identify disease-causing variants in the PSEN2 gene. This helps confirm whether a person's early-onset dementia is related to PSEN2-associated Alzheimer disease type 4. It also enables more informed recurrence risk counselling for family members. The test should not be used for general population screening or as a stand-alone diagnostic tool without clinical evaluation.

Test Code
3873
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Results are usually available in 3 to 4 weeks. This duration includes DNA extraction, quality control, NGS sequencing, data analysis, variant interpretation, and report preparation.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No fasting is required. The treating doctor should provide a referral and clinical history. A genetic counseling session is recommended before the test to draw a pedigree chart and discuss possible results and implications.

Method: Peripheral blood draw / dried blood spot on FTA card / submitted DNA sample

Step 2

Laboratory Analysis

A small blood sample will be collected in an EDTA tube by a trained phlebotomist. If an FTA card is used, one drop of blood is applied to the marked circles and allowed to air-dry.

Step 3

Report Delivery

There are no activity restrictions after sample collection. The sample is transported to the laboratory in a temperature-controlled packaging. The laboratory will process the sample for DNA extraction, NGS library preparation, sequencing, bioinformatics analysis, and clinical reporting.

Timeline: Results are usually available in 3 to 4 weeks. This duration includes DNA extraction, quality control, NGS sequencing, data analysis, variant interpretation, and report preparation.

Patient Instructions

1
Before the Test:A genetic counseling session should be completed before testing to review the purpose, risks, benefits, possible results, and implications for family members.
2
During the Test:A blood sample is obtained by venipuncture or a dried blood spot is collected on an FTA card. No sedation or special preparation is needed.
3
After the Test:After collection, the sample is sent to the laboratory for NGS processing. You may receive a genetic counseling session after the report is available to discuss results and next steps.

About This Test

Who Should Get This Test

The main purpose of this NGS genetic test is to identify disease-causing variants in the PSEN2 gene. This helps confirm whether a person's early-onset dementia is related to PSEN2-associated Alzheimer disease type 4. It also enables more informed recurrence risk counselling for family members. The test should not be used for general population screening or as a stand-alone diagnostic tool without clinical evaluation.

How to Prepare

  • No fasting required.
  • Carry valid identification and referral letter.
  • Inform the laboratory about any known genetic variant in the family.
  • Free home sample collection can be scheduled by booking online.

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"A PSEN2 variant has implications for the whole family. I strongly encourage any referring physician to include pretest genetic counseling, and if a pathogenic variant is found, to arrange post-test counseling for the patient and at-risk relatives."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample VolumeNot specified - depends on collection method
ContainerEDTA tube / FTA card / DNA storage vial
Collection MethodPeripheral blood draw / dried blood spot on FTA card / submitted DNA sample

Sample Stability

Whole blood in EDTA: transport to the laboratory as soon as possible; do not freeze.
FTA card: stable at room temperature in a dry environment.
Extracted DNA: stable for several weeks when stored at -20°C or below.
Sample Rejection Criteria:
  • Sample quantity insufficient.
  • Sample tube without patient identifiers.
  • Clotted sample or empty tube.
  • FTA card not dried or contaminated.
  • Incomplete test requisition or missing consent.

Understanding Your Results

Interpretation of this test should be performed by a clinical geneticist in combination with the referring physician. Variants are classified according to the American College of Medical Genetics and Genomics (ACMG) and Association for Molecular Pathology (AMP) guidelines. A laboratory report that states 'pathogenic variant detected' is considered a molecular confirmation of PSEN2-related Alzheimer disease type 4 when the clinical picture is consistent.
📊

Consistent with a molecular diagnosis of PSEN2-related Alzheimer disease type 4. Genetic counseling is recommended for the patient and family members.

Result type: Pathogenic / Likely pathogenic variant detected

📊

A PSEN2-related cause is unlikely, but Alzheimer disease due to other genetic or non-genetic causes cannot be ruled out.

Result type: No pathogenic / likely pathogenic variant detected

📊

The clinical significance is currently unknown. Testing of affected or at-risk family members may help reclassify the variant in the future.

Result type: Variant of uncertain significance (VUS)

📊

The variant is not considered disease-causing. Clinical evaluation should continue based on symptoms and other risk factors.

Result type: Benign / Likely benign variant detected

⚠️ When to Consult a Doctor:

If you or a relative have early-onset memory loss, unexplained confusion, behavioral changes, or a known family history of PSEN2-related Alzheimer disease, consult a neurologist or clinical geneticist for assessment. Genetic test results should also be discussed with a doctor before making medical or family-planning decisions.

Limitations

  • This test analyses only the PSEN2 gene; variants in PSEN1, APP, MAPT, GRN, C9orf72, and other dementia-associated genes are not covered.
  • A negative result does not exclude Alzheimer disease or another form of dementia.
  • Variants of uncertain significance may be reported and may require additional family studies.
  • Routine NGS may not detect all types of genetic changes, such as large copy-number variants or deep intronic variants.
  • Predictive testing in asymptomatic individuals should only be performed with formal genetic counseling and informed consent.

Risks & Considerations

  • Minor pain or bruising at the blood draw site.
  • Dizziness or light-headedness during blood collection.
  • Very low risk of infection or bleeding.
  • Psychological or emotional impact of predictive genetic information.
  • Potential implications for family relationships and insurability if predictive testing is performed.

Interfering Factors

  • Recent allogeneic bone marrow transplant or hematopoietic stem cell transplant may cause blood-derived DNA to match the donor rather than the person being tested.
  • Poor DNA quality or quantity due to improper sample storage or transport can affect sequencing.
  • Sample contamination or mislabelling can lead to unreliable results.
  • The presence of a large deletion, duplication, or structural rearrangement involving PSEN2 may not be detected by routine NGS.

Compare With Similar Tests

TestPSEN2 Gene Alzheimer Disease Type 4 NGS Genetic TestPSEN2 Single-Gene NGSEarly-Onset Alzheimer Disease PanelWhole Exome Sequencing
ComparisonPSEN2 Gene Alzheimer Disease Type 4 NGS Genetic Test

Frequently Asked Questions

What is the PSEN2 Gene Alzheimer Disease Type 4 NGS Genetic Test?
It is a targeted next-generation sequencing test that looks for disease-causing variants in the PSEN2 gene, which is associated with Alzheimer disease type 4.
What is the cost of the PSEN2 gene test at DNA Labs India?
The test costs Rs 20000. Free home sample collection is included for online bookings.
What type of sample is needed for this test?
The test can be performed on a blood sample, extracted DNA, or one drop of blood on an FTA card.
Is fasting required before the test?
No, fasting is not required for this NGS genetic test.
Who should take this test?
The test is meant for people with early-onset cognitive symptoms, a family history of early-onset Alzheimer disease, or a known PSEN2 mutation in the family. It should be ordered by a specialist after genetic counseling.
Which Alzheimer disease type is associated with PSEN2 mutations?
Pathogenic variants in PSEN2 are associated with Alzheimer disease type 4, which is generally an autosomal dominant early-onset form of Alzheimer disease.
What does a negative test result mean?
A negative result means that no pathogenic or likely pathogenic variant was identified in the PSEN2 gene. It does not rule out Alzheimer disease caused by other genes or non-genetic factors.
What is a variant of uncertain significance (VUS)?
A VUS is a genetic change whose clinical impact is not yet known. It may require family studies and additional data before it can be classified as benign or pathogenic.
How long does it take to get the genetic test report?
Reports are generally delivered within 3 to 4 weeks after the sample is received in the laboratory.
Can this test be done on a healthy person to check future Alzheimer risk?
Predictive testing in healthy at-risk adults may be considered only after genetic counseling, informed consent, and a careful discussion of benefits, limitations, and emotional impact.
Is home sample collection available for this test?
Yes, DNA Labs India provides free home sample collection for online bookings in many cities across India.
How will I receive my genetic test report?
The report is shared through the online portal, email, or WhatsApp. A geneticist or referring physician should explain the result to you.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.